Volume 18, Issue 1 of Advances in Pulmonary Hypertension, “PH in Congenital Heart Disease (CHD),” guest edited by Dunbar Ivy, M.D., is dedicated to the transition between child and adult with pulmonary hypertension (PH) and congenital heart disease and the gaps in knowledge and differences in treatment guidelines between children and adults. Depending on the severity of PH and when a patient is diagnosed, as child or adult, guidelines for surgical intervention vary greatly.

This issue features articles on atrial septal defect and how it is treated, Eisenmenger Syndrome, pressure vs. flow-induced PH, and evaluation and ongoing approach to children with Down Syndrome who have PH or who are at risk of developing PH, as well as published original research, “Atrial Septal Defect-Associated Pulmonary Hypertension: Outcomes of Closure with a Fenestrated Device.”

Advances in Pulmonary Hypertension Editor-in Chief Deborah J. Levine, M.D., noted in the “Editor’s Memo” the importance of this topic for PH-treating clinicians. “Advances in therapies continue to improve for patients with CHD, making it possible for children to live well into adulthood. Complications, however, from both CHD and PH, still require the input from a multitude of specialists working together to improve survival and quality of life.”

Don’t miss an issue of Advances in Pulmonary Hypertension, PHA’s quarterly clinical review journal, which is now published exclusively online and available at no charge, 24/7, at AdvancesinPH.org. Readers may register on the Advances website.